Surat-based speciality chemicals firm, Aether Industries, has announced the execution of a contract/exclusive manufacturing agreement with Chemoxy International Ltd, a wholly owned subsidiary of France-based Seqens Group.
Seqens Group is an integrated global player in health, personal care, and speciality ingredients, and operates 16 production sites and nine R&D centres worldwide, with an annual revenue of Euro 1.1-bn.
Under this take-or-pay contract, Aether will exclusively produce a series of natural bio-based products for Seqens Group. The contract covers an initial period of three years, with production expected to commence within the next 10 months, targeting a volume of over 100-mt per year.
Dr. Aman Desai, Whole-time Director, Aether, said, “The manufacturing process, which involves advanced continuous reaction technology, was collaboratively developed by Aether and Seqens Group over the past three years. This venture is a significant milestone for Aether’s Renewables and Sustainability business segment, further establishing Aether as a leading India-based speciality chemical manufacturer and a provider of sustainable and carbon-neutral chemistry solutions across the industry spectrum around the world.”


23 August, 2024 15:01:53 IST 

















